GDPD4 Gene - Glycerophosphodiester Phosphodiesterase Domain Containing 4

Comprehensive genomic and functional analysis of GDPD4, a glycerophosphodiester phosphodiesterase implicated in lipid metabolism and cancer.

Gene Information Card

Symbol GDPD4
Full Name Glycerophosphodiester Phosphodiesterase Domain Containing 4
Gene Type Protein coding
Chromosomal Location 11q13.4
NCBI Gene ID 220082 ncbi.nlm.nih.gov/gene/220082
Ensembl ID ENSG00000137710
UniProt ID Q8N3F8
OMIM ID 615752
HGNC ID 28479
Aliases GDPD4, GDE4, MGC15619

Description

GDPD4 (glycerophosphodiester phosphodiesterase domain containing 4) encodes a member of the glycerophosphodiester phosphodiesterase family. The protein catalyzes the hydrolysis of glycerophosphodiesters to sn-glycerol-3-phosphate and corresponding alcohols, playing a role in phospholipid metabolism. GDPD4 is implicated in cellular signaling and has been studied in the context of cancer, where altered expression may influence tumor progression.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (general) Altered GDPD4 expression may affect phospholipid metabolism and signaling pathways involved in cell proliferation and survival. COSMIC mutation data; literature on expression changes in various cancers.
Prostate cancer GDPD4 expression is reported to be downregulated in prostate cancer tissues, potentially contributing to tumorigenesis. PubMed studies; expression profiling data.
Breast cancer GDPD4 mutations and expression changes have been observed in breast cancer samples. COSMIC; ClinVar; literature.

Expression Profile

Tissue Expression
Tissue nTPM level
Adipose tissue 5.2 Low
Brain 3.8 Low
Breast 4.1 Low
Colon 6.0 Medium
Kidney 7.5 Medium
Liver 2.9 Low
Lung 4.5 Low
Prostate 8.3 Medium
Skin 3.0 Low
Testis 12.1 High
Cell Line Expression
Cell Line nTPM Notes
HEK 293 4.8 Embryonic kidney cells
HeLa 3.2 Cervical cancer cells
MCF7 5.5 Breast cancer cells
PC3 6.1 Prostate cancer cells
A549 4.0 Lung cancer cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.101C>T (p.Thr34Met) Missense <0.01% Unknown; predicted benign by SIFT
c.205G>A (p.Gly69Ser) Missense <0.01% Unknown; predicted damaging by PolyPhen
c.412_413insA Frameshift <0.01% Likely loss of function
c.589C>T (p.Arg197*) Nonsense <0.01% Loss of function
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations (e.g., p.Arg197*, c.412_413insA) are predicted to result in truncated or non-functional protein, leading to loss of enzymatic activity.

Gain of Function (GOF)

No documented gain-of-function mutations for GDPD4.

Dominant Negative (DN)

No evidence of dominant-negative effects for GDPD4 mutations.

Pathways

Glycerophospholipid metabolism (Reactome: R-HSA-1483206)
Phospholipid catabolism (KEGG: map00564)

Protein Summary

GDPD4 encodes a 340-amino acid protein with a glycerophosphodiester phosphodiesterase domain. The protein is localized to the plasma membrane and catalyzes the cleavage of glycerophosphodiesters, contributing to phospholipid homeostasis. It is expressed in multiple tissues, with highest levels in testis. Structural analysis reveals a conserved catalytic site essential for enzymatic activity.

Related Products

Product name Cat.No. Species Gene ID
GDPD4 Knockout HEK293 Cell Line EDJ-KQ7812 Human 220032 Details Get a Quote
GDPD4 Knockout HeLa Cell Line EDJ-KQ59131 Human 220032 Details Get a Quote
GDPD4 Knockout A-549 Cell Line EDJ-KQ67605 Human 220032 Details Get a Quote
GDPD4 Knockout HCT 116 Cell Line EDJ-KQ75993 Human 220032 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: